Israel’s Elbit Imaging to up coupons on series I notes through August

By Rebecca Melvin

New York, June 12 – Elbit Imaging Ltd. said it will pay increased interest of 9% per annum on its series I notes from June to August, provided that noteholders do not call the notes for immediate repayment and/or exercise any of the collaterals during the three-month period.

The company and the series I holders approved the amendment, which will lift the interest rate from 6% currently, according to a company news release.

Tel Aviv-based Elbit Imaging operates in medical industries through its indirect holdings in Insightec Ltd. and Gamida Cell Ltd. and in land designated for sale in India and Eastern Europe.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.